Document Detail


Effect of clonidine and propranolol on venous smooth muscle from spontaneously hypertensive rats.
MedLine Citation:
PMID:  7138149     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Clonidine and propranolol reverse arterial smooth muscle hypertrophy in hypertensive animals. It is uncertain whether this is mediated by a reduction in pressure or withdrawal of sympathetic nerve activity to the vasculature. Veins obtained from spontaneously hypertensive rats undergo hypertrophy and thereby provide a model for the separation of pressure-dependent and independent effects of antihypertensive drugs. Clonidine (0.075 and 0.3 mg/kg/day) or propranolol (0.75 and 3.0 mg/kg/day), administered by Alzet minipump for three consecutive weeks to SHR and age and sex matched Wistar-Kyoto normotensive rats (WKY), produced dose-related reductions in systolic arterial pressure, without affecting central or portal venous or right ventricular pressure. Clonidine reversed the decreased extensibility and the biochemical correlates of hypertrophy which characterized the portal (PV) and vena caval veins (IVC) and pulmonary arteries (PA) obtained from SHR. Moreover, clonidine decreased the uptake of PAS-Schiff stain for neutral and acidic glycosaminoglycans (GAG's) and decreased the medial wall thickness of the PV, IVC and PA obtained from SHR. Clonidine did not affect these parameters in blood vessels obtained from WKY. Propranolol exerted actions similar to clonidine, but its effects were more variable and less effective than clonidine, despite equivalent reductions in arterial pressure. The data support the conclusion that clonidine can reverse the functional morphological derangements of venous and PA dysfunction in SHR. The effects appear to be independent of both a reduction in pressure and withdrawal of sympathetic tone to the blood vessels. The data suggest that clonidine, and to a lesser extent propranolol, may act directly on the veins, or indirectly by inhibiting the release or synthesis of a trophic nonadrenergic factor, to reverse the functional and structural changes in the veins.
Authors:
S Greenberg; W Wilborn
Related Documents :
2429109 - Study of the electrophysiologic properties of clonidine administered intravenously.
12196059 - Clonidine-induced hypertension in a patient with a spinal lesion.
9710529 - Noradrenaline release in the rat subfornical organ area to blood pressure changes.
1933999 - Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of ...
541039 - Clonidine and carotid baroreflex in essential hypertension.
23815169 - Distinct responses to mechanical grinding and hydrostatic pressure in luminescent chrom...
8299639 - High blood pressure and ventricular arrhythmias.
9201079 - Effect of octreotide on human sphincter of oddi motility following liver transplantation.
11686949 - Interventions for deliberately altering blood pressure in acute stroke.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Archives internationales de pharmacodynamie et de thérapie     Volume:  258     ISSN:  0003-9780     ISO Abbreviation:  Arch Int Pharmacodyn Ther     Publication Date:  1982 Aug 
Date Detail:
Created Date:  1982-12-16     Completed Date:  1982-12-16     Revised Date:  2012-01-12    
Medline Journal Info:
Nlm Unique ID:  0405353     Medline TA:  Arch Int Pharmacodyn Ther     Country:  BELGIUM    
Other Details:
Languages:  eng     Pagination:  234-59     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Body Water / metabolism
Clonidine / pharmacology*
Female
Glycosaminoglycans / metabolism
Hemodynamics / drug effects
Hypertension / physiopathology*
Lipid Metabolism
Male
Muscle Proteins / metabolism
Muscle, Smooth, Vascular / drug effects*
Propranolol / pharmacology*
Proteins / metabolism
Rats
Rats, Inbred Strains
Grant Support
ID/Acronym/Agency:
7-K04 HL00428-04/HL/NHLBI NIH HHS; HL22177/HL/NHLBI NIH HHS; HL22215/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Glycosaminoglycans; 0/Muscle Proteins; 0/Proteins; 4205-90-7/Clonidine; 525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Functional and structural changes in veins in spontaneous hypertension.
Next Document:  Seizure activity in animals given enprofylline and theophylline, two xanthines with partly different...